Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials, also abroad
89 open Hypertrophic cardiomyopathy trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM has 13 sites in Spain and runs in 19 countries. If a site near you is full, another one may still take people.
See Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM in all 19 countries